NVNO Fundamental Analysis - ENVVENO MEDICAL CORP

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to NVNO. NVNO was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While NVNO has a great health rating, there are worries on its profitability. NVNO is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

NVNO had negative earnings in the past year.

NVNO had a negative operating cash flow in the past year.

In the past 5 years NVNO always reported negative net income.

NVNO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

NVNO has a Return On Assets of -63.07%. This is in the lower half of the industry: NVNO underperforms 70.53% of its industry peers.

NVNO has a Return On Equity of -69.78%. This is comparable to the rest of the industry: NVNO outperforms 43.16% of its industry peers.

		Industry Rank	Sector Rank
ROA	-63.07%
ROE	-69.78%
ROIC	N/A

ROA(3y)-52.5%

ROA(5y)-55.71%

ROE(3y)-55.94%

ROE(5y)-67.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NVNO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for NVNO has been increased compared to 1 year ago.

Compared to 5 years ago, NVNO has more shares outstanding

NVNO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

NVNO has an Altman-Z score of -5.05. This is a bad value and indicates that NVNO is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -5.05, NVNO is not doing good in the industry: 68.95% of the companies in the same industry are doing better.

NVNO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-5.05

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NVNO has a Current Ratio of 11.81. This indicates that NVNO is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 11.81, NVNO belongs to the top of the industry, outperforming 95.26% of the companies in the same industry.

NVNO has a Quick Ratio of 11.81. This indicates that NVNO is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of NVNO (11.81) is better than 96.32% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	11.81
Quick Ratio	11.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NVNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.08%, which is quite good.

EPS 1Y (TTM)16.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-6.45%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NVNO will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.86% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y13.26%

EPS Next 2Y9.4%

EPS Next 3Y12.02%

EPS Next 5Y12.86%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVNO. In the last year negative earnings were reported.

Also next year NVNO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NVNO's earnings are expected to grow with 12.02% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y9.4%

EPS Next 3Y12.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NVNO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ENVVENO MEDICAL CORP

NASDAQ:NVNO (9/11/2025, 5:36:06 PM)

After market: 0.7801 -0.01 (-0.75%)

0.786

+0.07 (+9.18%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)07-31 2025-07-31/amc

Earnings (Next)10-29 2025-10-29/bmo

Inst Owners21.2%

Inst Owner Change42.55%

Ins Owners0.92%

Ins Owner Change0%

Market Cap15.13M

Analysts43.33

Price Target12.75 (1522.14%)

Short Float %2.79%

Short Ratio0.57

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)10.51%

Min EPS beat(2)-15.55%

Max EPS beat(2)36.56%

EPS beat(4)2

Avg EPS beat(4)8.25%

Min EPS beat(4)-15.55%

Max EPS beat(4)36.56%

EPS beat(8)6

Avg EPS beat(8)13%

EPS beat(12)7

Avg EPS beat(12)6.26%

EPS beat(16)8

Avg EPS beat(16)-14.08%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)3.23%

EPS NY rev (1m)0%

EPS NY rev (3m)11.48%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)-100%

Revenue NY rev (1m)N/A

Revenue NY rev (3m)-100%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.46
P/tB	0.46
EV/EBITDA	N/A

EPS(TTM)-1.2

EYN/A

EPS(NY)-1.02

Fwd EYN/A

FCF(TTM)-0.89

FCFYN/A

OCF(TTM)-0.89

OCFYN/A

SpS0

BVpS1.72

TBVpS1.72

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-63.07%
ROE	-69.78%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-52.5%

ROA(5y)-55.71%

ROE(3y)-55.94%

ROE(5y)-67.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	4.4%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	11.81
Quick Ratio	11.81
Altman-Z	-5.05

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)23.4%

Cap/Depr(5y)99.37%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)16.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-6.45%

EPS Next Y13.26%

EPS Next 2Y9.4%

EPS Next 3Y12.02%

EPS Next 5Y12.86%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-10.16%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y5.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y4.99%

OCF growth 3YN/A

OCF growth 5YN/A

ENVVENO MEDICAL CORP (NVNO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens